Skip to content

Multilevel Growth Curve Analyses of Behavioral Activation for Anhedonia (BATA) and Mindfulness-Based Cognitive Therapy Effects on Anhedonia and Resting-State Functional Connectivity: Interim Results of a Randomized Trial

P. Cernasov, E. Walsh, J. Kinard, L. Kelley, Rachel C Phillips, Angela Pisoni, T. Eisenlohr-Moul, Macey L. Arnold, Sarah C. Lowery, Marcy Ammirato, K. Truong, Gabriela A. Nagy, Jason A. Oliver, Kevin Haworth, Moria J Smoski, G. Dichter

Journal of Affective Disorders May 28, 2021 DOI: 10.1016/j.jad.2021.05.054 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 73
Population Medication-free, transdiagnostic, anhedonic adults
Duration Up to 15 therapy sessions; up to four 7T MRI scans before, during, and after treatment
Topics Meditation
Key findings Both Behavioral Activation Therapy for Anhedonia and Mindfulness-Based Cognitive Therapy reduced anhedonia symptoms, with no difference between treatments. Reductions in resting-state functional connectivity within the default mode and frontoparietal networks, and between them, co-occurred with anhedonia improvement. Within-person connectivity changes were unrelated to anhedonia changes, while higher-than-average frontoparietal connectivity was related to lesser anhedonia across timepoints.

Abstract

Background: The neural mechanisms associated with anhedonia treatment response are poorly understood. Additionally, no study has investigated changes in resting-state functional connectivity (rsFC) accompanying psychosocial treatment for anhedonia.

Methods: We evaluated a novel psychotherapy, Behavioral Activation Therapy for Anhedonia (BATA, n=38) relative to Mindfulness-Based Cognitive Therapy (MBCT, n=35) in a medication-free, transdiagnostic, anhedonic sample in a parallel randomized controlled trial. Participants completed up to 15 sessions of therapy and up to four 7T MRI scans before, during, and after treatment (n=185 scans). Growth curve models estimated change over time in anhedonia and in rsFC using average region-of-interest (ROI)-to-ROI connectivity within the default mode network (DMN), frontoparietal network (FPN), salience network, and reward network. Changes in rsFC from pre- to post-treatment were further evaluated using whole-network seed-to-voxel and ROI-to-ROI edgewise analyses.

Results: Growth curve models showed significant reductions in anhedonia symptoms and in average rsFC within the DMN and FPN over time, across BATA and MBCT. There were no differences in anhedonia reductions between treatments. Within-person, changes in average rsFC were unrelated to changes in anhedonia. Between-person, higher than average FPN rsFC was related to lesser anhedonia across timepoints. Seed-to-voxel and edgewise rsFC analyses corroborated reductions within the DMN and between the DMN and FPN over time, across the sample.

Conclusions: Reductions in rsFC within the DMN, FPN, and between these networks co-occurred with anhedonia improvement across two psychosocial treatments for anhedonia. Future anhedonia clinical trials with a waitlist control group should disambiguate treatment versus time-related effects on rsFC.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics